Charles River Laboratories (CRL) Tops Q4 EPS by 29c, Revenues Beat; Offers FY21 EPS Guidance Above Consensus
Go back to Charles River Laboratories (CRL) Tops Q4 EPS by 29c, Revenues Beat; Offers FY21 EPS Guidance Above Consensus| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 278.06 -3.61 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $281.67 | 52 Week High | $89.18 | |||
| Open | $281.26 | 52 Week Low | $65.70 | |||
| Day High | $283.00 | P/E | 129.33 | |||
| Day Low | $276.00 | EPS | $2.15 | |||
| Volume | 1,481,164 | |||||
